Clinical Trial Update: Efficacy and Safety of Probiotics in Neonatal Hyperbilirubinemia [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial is evaluating the efficacy and safety of probiotics for neonatal hyperbilirubinemia; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neonatal Hyperbilirubinemia

Drugs mentioned

• Probiotics

Snippet

Sponsor: Hormozgan University of Medical Sciences | Conditions: Hyperbilirubinemia, Neonatal | Phase 3 | Status: UNKNOWN